Zhongnan Medical Journal Press

Home Results

A total of 33 result was found. Results that relate to ZHANG Ji

Clinical observation of Zishen Ningxin capsule combined with telmisartan in the treatment of perimenopausal hypertension

Published on Chinese Journal of Pharmacoepidemiology 2024,33(1):52-59.
920 times 531 times

WANG Bei DU Mingmin WANG Chengyi FU Da ZHANG Jing WANG Qiang

Zishen Ningxin capsule Telmisartan Perimenopause Hypertension
Details
Establishment and application of drug use evaluation criteria of fibrinogenase for injection

Published on Chinese Journal of Pharmacoepidemiology 2024,33(2):145-151.
944 times 489 times

REN Ruiqin ZHANG Jing GONG Yizhen ZHANG Jinhua

Fibrinogenase for injection Drug use evaluation Standard Expert consultation Rational drug use
Details
Teriparatide treatment for osteoporosis: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(1):75-84.
782 times 477 times

LYU Peng ZHANG Jingli WAN Yuansheng HUANG Yifei YOU Ruxu

Teriparatide Osteogenesis Safety Effectiveness Economy Rapid health technology assessment
Details
Combination of Chinese and Western therapy for crowned dens syndrome: a case report

Published on Journal of Mathematical Medicine 2024,37(1):68-72.
1634 times 492 times

ZHANG Jitao FAN Chenghu QI Bingxian WU Yize HU Xiangxin LI Zhaocheng

Crowned dens syndrome Combination of Chinese and Western medicine Case report
Details
Research progress on the mechanism of long non-coding RNA LINC00641 in the development of malignant tumors

Published on New Medicine 2024,34(1):88-98.
1885 times 604 times

GUO Mengmeng MING Daojing REN Yiming QIAN Xinhang YANG Shisong WANG Congcong LU Peiwen ZHANG Jinhui YUAN Shuai XI Shu ZENG Xiantao

Long non-coding RNAs LINC00641 Malignant tumor
Details
Establishment and application of drug use evaluation criteria for roxadustat

Published on Chinese Journal of Pharmacoepidemiology 2024,33(2):128-136.
847 times 488 times

HUANG Lingfang HONG Shanshan ZHANG Jinhua HUANG Xuhui

Roxadustat Drug utilization evaluation Delphi method Rational drug use
Details
Predicting human microbe-drug associations based on graph attention network

Published on Journal of Mathematical Medicine 2024,37(2):81-90.
903 times 304 times

SHI Sairu KONG Shu ZHANG Ji

Microbe-drug associations Multiple kernel fusion Graph attention network Heterogeneous network Cross validation
Details
Establishment and application of drug use evaluation criteria of argatroban

Published on Chinese Journal of Pharmacoepidemiology 2024,33(2):121-127.
852 times 330 times

DAI Hengfen ZHENG Caiyun LIU Yunchun ZHANG Hong LIU Maobai ZHANG Jinghua

Argatroban Drug use evaluation criteria Expert consultation method Rational drug use
Details
Drug use evaluation of ozagrel sodium based on weighted TOPSIS method

Published on Chinese Journal of Pharmacoepidemiology 2024,33(2):137-144.
676 times 302 times

ZHU Shanshan WANG Na CAI Huiya ZHANG Jinhua

Ozagrel sodium Drug use evaluation Weighted TOPSIS method Delphi method Rational drug use
Details
Mechanism research of PI3K/AKT pathway regulating PHF19 gene expression in prostate cancer

Published on New Medicine 2024,34(2):121-128.
1147 times 1446 times

MING Daojing GUO Mengmeng ZHANG Jinhui LIU Mengyang SHI Minghui LIU Shuyan YUAN Shuai ZENG Xiantao

PI3K/AKT TP63 PHF19 Prostate cancer
Details
Research progress of Toll-like receptors in calcified aortic valve disease

Published on New Medicine 2024,34(2):217-225.
908 times 1458 times

REN Yiming ZHANG Jinhui WANG Congcong WANG Tiankun REN Xuequn ZHOU Jianliang

Calcified aortic valve disease Toll-like receptor The inflammatory response
Details
Analysis of volatile constituents in different parts of Huai chrysanthemum by GC-MS combined with stoichiometry

Published on Frontiers in Pharmaceutical Sciences 2024,27(2):209-219.
1009 times 366 times

GUO Mengzhen LI Meng DENG Xiaoyan LIU Shuyan WANG Xiaolan SUN Xiaoya ZHANG Jingke ZHENG Xiaoke FENG Weisheng

Huai chrysanthemumin Different parts Volatile oil Gas chromatography-mass spectrometry Chemometrics
Details
The expression of ASXL3 in prostate cancer

Published on New Medicine 2024,34(3):282-290.
1050 times 908 times

ZHANG Jinhui LIU Mengyang CUI Jinlong REN Yiming CAI Yi MING Daojing REN Xuequn YUAN Shuai

ASXL3 Prostate cancer Prognosis Immune infiltration Biomarkers
Details
Transurethral plasmakinetic resection of prostate in high-risk benign prostatic hyperplasia patients: a multicenter prospective study

Published on New Medicine 2024,34(4):381-390.
2117 times 1413 times

LI Fei GENG Jie CHEN Hongbo ZHOU Zhijun LIU Xiaohua SHI Hongbo DU Dan ZHU Tao ZHANG Jingyu LI Xiaodong QUE Hui SONG Hongfei YAO Qisheng DOU Zhongling RUAN Jianzhong ZHENG Jiang ZHU Ziqing REN Xuanyi HUANG Qiao GONG Kan LIU Tongzu HE Dalin ZENG Xiantao

Transurethral plasmakinetic resection of prostate Benign prostatic hyperplasia High-risk patients Cardiovascular diseases
Details
Drug use evaluation of bivalirudin for injection based on weighted TOPSIS method

Published on Chinese Journal of Pharmacoepidemiology 2024,33(4):361-370.
1428 times 417 times

LI Ruijuan LI Meijuan MI Xiaolong CHEN Weihong LI Zhihong WANG Xiaomin ZHANG Jinhua

Bivalirudin Drug use evaluation Weighted TOPSIS method Rational drug use
Details